Skip to content
PlaceLab Network

Zimbabwe Rejects ‘Unbalanced’ US Healthcare Assistance Agreement Due to Information Fears

Medical aid image
The offered US funding would have supported initiatives for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has turned down a significant American healthcare agreement worth $367m (272 million pounds) spanning five years because of the United States' insistence on confidential biological samples.

This move was revealed after a government memo dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the deal was "skewed".

An official representative has since stated that the United States was requesting health data for research and commercial purposes but was not willing to share the benefits from any future treatments.

"We are forced to start the difficult and regrettable task of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the United States had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has called for more negotiations to secure a agreement acceptable to all parties so the nation's critical HIV treatment initiative can proceed.

Wider Context

This rejection follows a similar situation in Kenya, where a high court blocked a related deal with the US after concerns were filed about the safety of citizens' health data.

Since returning to the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).

USAID had managed assistance for the US government, but Trump stated its expenditure was "wasteful" and his government was seeking government-to-government agreements to enhance transparency and accountability.

According to reports, Sixteen African countries have to date agreed to these new agreements, constituting over $18.3bn in committed funds.

Specifics of the Rejected Deal

The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We believe this cooperation could have provided immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on antiretroviral therapy through US-supported initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".

"Our nation was requested to provide its biological resources and data indefinitely, with no corresponding guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that could result from that provided information," Mangwana explained.

"Put simply, our nation would provide the raw materials for scientific discovery with no certainty that the resulting innovations would be available to our population if a future pandemic emerge."

Sovereignty and International Frameworks

He also noted that the American exit from the global health body and its push of bilateral health agreements were upending systems previously established through the international health agency.

Mangwana cited its Pandemic Benefit-Sharing scheme created to manage future global health emergencies.

"This framework is intended to ensure that when a nation provides its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."

These objections regarding the US deal "are not meant as opposition to America," he added.

"We are open to continued dialogue with our American counterparts on how future collaboration could be arranged in a way that respects the independence and dignity of both nations."

Medical Community Response

Medical experts expressed it acknowledged the government's concerns, but urged that talks must proceed since much of the country's Aids initiatives depended on international support.

"In cases where technical issues arise, including those involving information security or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," the group added.

This impasse underscores the complex tensions between receiving vital international aid and safeguarding local interests in an increasingly interconnected world.

By

Christine Avery

Elena is an urban researcher and writer passionate about smart cities and community-driven development.

PlaceLab Network

Type to search articles.